{"slideshow_credits": null, "snippet": "The president of a drug company responds to an article about resistance to antibiotics.", "abstract": null, "section_name": "Opinion", "print_page": "18", "document_type": "article", "byline": [], "web_url": "http://www.nytimes.com/2013/06/08/opinion/developing-new-antibiotics.html", "lead_paragraph": "The president of a drug company responds to an article about resistance to antibiotics.", "headline": {"main": "Developing New Antibiotics", "print_headline": "Developing New Antibiotics", "content_kicker": "Letter", "kicker": "Letter"}, "_id": "51b893d67e0d9c0839d275f7", "word_count": "192", "multimedia": [], "pub_date": "2013-06-08T00:00:00Z", "source": "The New York Times", "news_desk": "Letters", "keywords": [{"value": "Antibiotics", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Prices (Fares, Fees and Rates)", "name": "subject", "is_major": "N", "rank": "3"}], "blog": [], "subsection_name": null, "type_of_material": "Letter"}